Bicycle Therapeutics plc - Ordinary Shares, nominal value GBP 0.01 per share (BCYC)
CUSIP: 088786108
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Ordinary Shares, nominal value GBP 0.01 per share
- Shares outstanding
- 50,351,032
- Total 13F shares
- 24,236,173
- Share change
- +702,435
- Total reported value
- $618,449,426
- Put/Call ratio
- 2033%
- Price per share
- $25.52
- Number of holders
- 84
- Value change
- +$18,484,148
- Number of buys
- 38
- Number of sells
- 38
Quarterly Holders Quick Answers
What is CUSIP 088786108?
CUSIP 088786108 identifies BCYC - Bicycle Therapeutics plc - Ordinary Shares, nominal value GBP 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 088786108:
Top shareholders of BCYC - Bicycle Therapeutics plc - Ordinary Shares, nominal value GBP 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP |
13F
|
Company |
5.6%
|
2,819,045
|
$59,961,087 | — | 31 Mar 2023 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
3.9%
|
1,948,000
|
$41,433,960 | — | 31 Mar 2023 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
3.6%
|
1,816,781
|
$38,642,932 | — | 31 Mar 2023 | |
| Kate Bingham |
3/4/5
|
Director |
—
class O/S missing
|
1,870,379
|
$32,731,633 | — | 13 Jul 2021 | |
| MORGAN STANLEY |
13F
|
Company |
3%
|
1,507,749
|
$32,069,822 | — | 31 Mar 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.9%
|
1,474,378
|
$31,363,631 | — | 31 Mar 2023 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
2.8%
|
1,408,831
|
$29,965,835 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
2.6%
|
1,303,211
|
$25,513,730 | — | 31 Mar 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2%
|
1,009,500
|
$21,472,065 | — | 31 Mar 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
1.9%
|
967,347
|
$20,575,471 | — | 31 Mar 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.7%
|
843,814
|
$17,947,924 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.6%
|
802,400
|
$17,067,048 | — | 31 Mar 2023 | |
| Logos Global Management LP |
13F
|
Company |
1.5%
|
750,000
|
$15,952,500 | — | 31 Mar 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.5%
|
736,000
|
$15,654,720 | — | 31 Mar 2023 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.4%
|
699,328
|
$14,874,707 | — | 31 Mar 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
1.2%
|
582,558
|
$12,391,009 | — | 31 Mar 2023 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1%
|
519,573
|
$11,051,000 | — | 31 Mar 2023 | |
| AXA S.A. |
13F
|
Company |
0.91%
|
460,125
|
$9,786,859 | — | 31 Mar 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.82%
|
411,800
|
$8,758,986 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.63%
|
318,076
|
$6,766,000 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0.57%
|
287,147
|
$6,107,617 | — | 31 Mar 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.41%
|
207,112
|
$4,405,273 | — | 31 Mar 2023 | |
| Rubric Capital Management LP |
13F
|
Company |
0.41%
|
205,423
|
$4,369,347 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.37%
|
187,900
|
$3,996,633 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.36%
|
178,932
|
$3,805,883 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.32%
|
160,576
|
$3,415,452 | — | 31 Mar 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.29%
|
147,799
|
$3,143,685 | — | 31 Mar 2023 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.26%
|
131,800
|
$2,803,000 | — | 31 Mar 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.24%
|
122,781
|
$2,612,000 | — | 31 Mar 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.24%
|
122,200
|
$2,599,194 | — | 31 Mar 2023 | |
| HighVista Strategies LLC |
13F
|
Company |
0.18%
|
92,434
|
$1,966,071 | — | 31 Mar 2023 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.18%
|
88,676
|
$1,886,139 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.17%
|
87,138
|
$1,853,000 | — | 31 Mar 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.16%
|
80,719
|
$1,716,893 | — | 31 Mar 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.16%
|
80,595
|
$1,714,256 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.15%
|
76,649
|
$1,630,326 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.13%
|
67,200
|
$1,429,344 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
61,900
|
$1,317,000 | — | 31 Mar 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.12%
|
60,100
|
$1,278,327 | — | 31 Mar 2023 | |
| Bellevue Group AG |
13F
|
Company |
0.11%
|
53,200
|
$1,131,564 | — | 31 Mar 2023 | |
| J. Goldman & Co LP |
13F
|
Company |
0.1%
|
49,944
|
$1,062,309 | — | 31 Mar 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.1%
|
48,439
|
$1,030,298 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.09%
|
44,573
|
$948,068 | — | 31 Mar 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.09%
|
43,807
|
$931,775 | — | 31 Mar 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
42,979
|
$914,163 | — | 31 Mar 2023 | |
| Jump Financial, LLC |
13F
|
Company |
0.07%
|
37,737
|
$802,666 | — | 31 Mar 2023 | |
| Dominic Smethurst |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
71,699
mixed-class rows
|
$642,233 | — | 03 Jan 2023 | |
| Caption Management, LLC |
13F
|
Company |
0.05%
|
26,000
|
$553,020 | — | 31 Mar 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.05%
|
25,888
|
$550,000 | — | 31 Mar 2023 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.05%
|
25,136
|
$534,643 | — | 31 Mar 2023 |
Institutional Holders of Bicycle Therapeutics plc - Ordinary Shares, nominal value GBP 0.01 per share (BCYC) as of Q2 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.